FERGUSON KAREN M 4

4 · Track Group, Inc. · Filed Apr 17, 2018

Form 4

Period: 2017-11-30

Director

Transactions

Award
Options
2018-01-26+9,191→ 9,191 total
Exercise: $1.15From: 2017-01-01Exp: 2021-12-31→ Common Stock (9,191 underlying)
Disposition to Issuer
Options
2017-11-30−9,000→ 0 total
Exercise: $5.00From: 2016-07-01Exp: 2023-06-30→ Common Stock (9,000 underlying)
Disposition to Issuer
Options
2018-01-26−9,191→ 0 total
Exercise: $4.50From: 2017-01-01Exp: 2021-12-31→ Common Stock (9,191 underlying)
Award
Options
2017-11-30+9,000→ 9,000 total
Exercise: $1.24From: 2016-07-01Exp: 2023-06-30→ Common Stock (9,000 underlying)
Disposition to Issuer
Options
2018-01-26−5,882→ 0 total
Exercise: $7.20From: 2016-10-01Exp: 2021-09-30→ Common Stock (5,882 underlying)
Award
Options
2018-01-26+5,882→ 5,882 total
Exercise: $1.15From: 2016-10-01Exp: 2021-09-30→ Common Stock (5,882 underlying)
Disposition to Issuer
Options
2018-01-26−3,529→ 0 total
Exercise: $7.20From: 2016-09-30Exp: 2021-09-29→ Common Stock (3,529 underlying)
Award
Options
2018-01-26+3,529→ 3,529 total
Exercise: $1.15From: 2016-09-30Exp: 2021-09-29→ Common Stock (3,529 underlying)
Disposition to Issuer
Options
2018-01-26−12,195
Exercise: $3.36From: 2017-04-01Exp: 2022-03-31→ Common Stock (12,195 underlying)
Award
Options
2018-01-26+12,195→ 12,195 total
Exercise: $1.15From: 2017-04-01Exp: 2022-03-31→ Common Stock (12,195 underlying)

Footnotes (2)

[F1]The reported transactions involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $1.24 per share, which modifications were approved in advance by the Issuer's Board of Directors on November 30, 2017. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively.
[F2]The reported transactions involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $1.15 per share, which modifications were approved in advance by the Issuer's Board of Directors on January 26, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively.

Documents

1 file